Johns Hopkins Hospital Home
Search

 

Home

Referring Physicians

Publications

Blood Disorders

Hospital Home

Blood Disorders Homepage

 

 

  CONDITION TOPICS

 

 

Reading Room

 

 

Making an Appointment

 

Our Locations

 

Finding a Doctor

 

Seeking New Cures

 

Educating Professionals

 

Supporting Hopkins Medicine

 

 

 

  OTHER HEALTH TOPICS

Blood Component Therapy

The process of transfusing only that portion of the blood needed by the patient is called blood component therapy. It allows a single unit (one pint) of donated blood to benefit more than one patient.  Red blood cells and platelets are the most frequently transfused blood components.  Following are descriptions of blood products used in blood component transfusions.

Whole blood

Whole blood consists of red blood cells, white blood cells and platelets, all of which float in a colorless, watery fluid called plasma.  Transfusions of whole blood are rarely required.  However, if a person has undergone certain types of major surgery or has suffered major trauma such as a car accident or gunshot wound requiring emergency surgery, a transfusion of whole blood may be necessary.  Whole blood can be stored for 5 weeks.

Packed red cells and frozen red cells

Red blood cells contain hemoglobin, the protein that carries oxygen throughout the body. Packed red cells have about 40 percent of the volume of whole blood.  Using frozen red cells reduces the risk of infusing antigens, or foreign bodies, that the body might regard as potentially dangerous.  Recent advances have made it possible to store red blood cells for up to 42 days.  A transfusion of red blood cells may be necessary for people who have suffered acute trauma before surgery or for people with anemia who are having surgery.

Platelet concentrates

Platelets are cellular components that help in the clotting process.  A platelet transfusion is used if there is a platelet disorder or when massive blood loss has occurred.  Platelets are stored for up to five days at room temperature.  A platelet transfusion may be necessary after prolonged surgery.

Cryoprecipitated antihemophilic factor

Cryoprecipitated antihemophilic factor, an antihemophilic concentrate, is prepared from plasma and is rich in clotting factors.  It is used in people with hemophilia, von Willebrand's disease or other major coagulation abnormalities to prevent or control bleeding.

Last Updated: 10/1/2002
The Johns Hopkins University 1996-2003.  All rights reserved.  This information is not intended to provide advice on personal medical matters, nor is it intended to be a substitute for consultation.

 

    

 

 

 

Johns Hopkins School of Medicine
Johns Hopkins University
Johns Hopkins Medicine
U.S.News and World Report America's Best HospitalBest Graduate School 2007 US News and World Report